Home/Filings/4/0001209191-23-017430
4//SEC Filing

PURA VIDA INVESTMENTS, LLC 4

Accession 0001209191-23-017430

CIK 0001642380other

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 8:54 PM ET

Size

10.3 KB

Accession

0001209191-23-017430

Insider Transaction Report

Form 4
Period: 2023-03-06
Kamen Efrem
10% Owner
Transactions
  • Other

    Common Stock

    2023-03-063,890,1114,589,571 total(indirect: By the Managed Accounts.)
Holdings
  • Common Stock

    (indirect: By Pura Vida X Fund LP)
    767,952
  • Common Stock

    (indirect: By Trust)
    1,381,438
  • Common Stock

    (indirect: By Pura Vida Master Fund, Ltd.)
    7,427,202
Transactions
  • Other

    Common Stock

    2023-03-063,890,1114,589,571 total(indirect: By the Managed Accounts.)
Holdings
  • Common Stock

    (indirect: By Pura Vida Master Fund, Ltd.)
    7,427,202
  • Common Stock

    (indirect: By Pura Vida X Fund LP)
    767,952
  • Common Stock

    (indirect: By Trust)
    1,381,438
Footnotes (4)
  • [F1]As of March 6, 2023, the Reporting Persons no longer have voting and dispositive power for certain Managed Accounts and therefore such shares are no longer deemed beneficially owned by the Reporting Persons.
  • [F2]Not applicable.
  • [F3]Shares reported herein are owned by Pura Vida Master Fund, Ltd., Pura Vida X Fund LP, and Lockheed Martin Corporation Master Retirement Trust (the "Retirement Trust") and certain separately managed accounts (the "Managed Accounts" and collectively, the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager or sub-adviser to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI.
  • [F4]By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any.

Issuer

Oncocyte Corp

CIK 0001642380

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001590144

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 8:54 PM ET
Size
10.3 KB